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ABSTRACT
There is no satisfactory conventional treatment for patients who experience irreversible salivary gland
damage after therapeutic radiation for head and neck cancer or because of Sjögren’s syndrome. Ad-
ditionally, if most parenchyma is lost, these patients also are not candidates for evolving gene transfer
strategies. To help such patients, several years ago we began to develop an artificial salivary gland. In the
present study, we used a non-human primate tissue source, parotid glands from rhesus monkeys, to
obtain potential autologous graft cells for development of a prototype device for in situ testing. Herein, we
present 3 major findings. First, we show that primary cultures of rhesus parotid gland (RPG) cells are
capable of attaining a polarized orientation, with Na+/K+-adenosine triphosphatase, zonula occludens-1,
and claudin-1 distributed in specific domains appropriate for epithelial cells. Second, we show that RPG
cells exhibit 2 essential epithelial functions required for graft cells in an artificial salivary gland device
(i.e., an effective barrier to paracellular water flow and the generation of a moderate transepithelial
electrical resistance). Third, we show that RPG cells can express functional water channels, capable of
mediating directional fluid movement, after transduction by adenoviral and adeno-associated virus type 2
vectors. Together these results demonstrate that it is feasible to individually prepare RPG cells for
eventual use in a prototype artificial salivary gland.
INTRODUCTION
THE PRIMARY FUNCTION OF SALIVARY GLANDS is to producean exocrine secretion, saliva, which plays an essen-
tial role in the protection and maintenance of the tissues of
the upper gastrointestinal (GI) tract, as well as in initial
food digestion.1 Not surprisingly, patients who lack ade-
quate salivary gland function, for whatever reason, suffer
from dysphagia, frequent oral soft and hard tissue in-
fections (e.g., candidiasis, dental caries), diminished
mucosal wound healing, and considerable pain and dis-
comfort.2,3
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There are 2 common reasons for the irreversible loss of
salivary gland function: the autoimmune disorder Sjögren’s
syndrome and the radiotherapy that is part of the treatment
for head and neck cancers. Patients with these conditions, for
different etiopathologic reasons, experience the loss of the
fluid- and protein-secreting acinar cells, and their salivary
secretion is dramatically reduced. For many, most or all of
the gland tissue is obliterated, leaving a massive inflam-
matory cell infiltrate (Sjögren’s syndrome) or substantial
fibrosis (both conditions). Such patients have little to no
epithelial tissue remaining, rendering them inappropriate
candidates for gene transfer strategies that currently are
being evaluated.4–7
In an effort to help these patients, several years ago we
began efforts to develop an artificial salivary gland.8–10 The
envisioned device consists of a blind-end tube constructed of
a biodegradable polymer (poly-L-lactic acid; PLLA), coated
on its inner (luminal) surface with an extracellular matrix
protein (e.g., fibronectin, collagen I), upon which sits a
monolayer of polarized epithelial cells capable of unidirec-
tional fluid movement.10 A major hurdle in the development
of this device has been the latter component.11 Recently, we
developed a method to obtain primary salivary epithelial
cells capable of forming a polarized monolayer.12 These
cells were apparently of ductal origin, and thus, are incapable
of unidirectional fluid secretion.13–15 A significant hurdle in
developing this device is the choice of an appropriate model
for testing a prototype in vivo, because conventional rodent
models are too small for effective testing of the in situ pla-
cement and function of an artificial salivary gland.16
In the present study, we used a non-human primate tissue,
parotid glands from rhesus monkeys, as a cell source. Rhesus
monkeys provide a sizable animal suitable for eventual
in vivo testing of a prototype device. Herein we report the
successful isolation of primary salivary ductal epithelial
cells, capable of attaining polarized-orientation and mem-
brane barrier function. Using this model glandular epithe-
lium, we also demonstrate functional re-engineering of these
cells, with adenoviral and adeno-associated viral (AAV) vec-
tors encoding the archetypical water channel aquaporin-1,17
leading to high levels of directional fluid movement.
MATERIALS AND METHODS
Rhesus parotid gland cell preparation and culture
Rhesus parotid glands (RPGs) were rinsed twice in Dul-
becco’s modified Eagle medium (DMEM) supplemented
200U/mL penicillin and 200 mg/mL streptomycin (Bio-
fluids, Rockville,MD) and then transferred to a 100-mmdish
with 3mLDMEM to remove the fibrous capsule. Next, using
curved scissors, the tissue was mechanically minced into a
slurry, followed by incubation in 35mL of ‘‘dissociat-
ion buffer’’ for 3 to 4 h at 378C, with vigorous vortexing
every 30min. The dissociation buffer contained a mixture of
0.2U/mL Liberase Blendzyme#3 and 0.1% Trypsin (both
from Roche Diagnostic/Boehringer, Indianapolis, IN) in
DMEM. The cell suspension was centrifuged at 1500 rpm for
5min, the supernatant was discarded, and the resulting cell
pellet was resuspended in 10mL Hepato-Stim medium
(Becton Dickinson, Bedford, MA) supplemented with
5% antibiotic/antimycotic solution (500U/mL penicillin,
500 mg/mL streptomycin, and 12.5 mg/mL fungizone; Bio-
fluids) and 1% glutamine. This cell suspension was then
filtered through a 70-mm cell strainer (Becton Dickinson),
then plated on a 100-mm tissue culture dish, and incubated at
378C overnight in 5% carbon dioxide (CO2). Thereafter, the
culture medium was changed twice a week, and the cells
were passaged, at a 1:3 split ratio, using trypsin/versene
(0.05% trypsin, 0.02% versene; Biofluids) when the plate
reached 70% to 80% confluence. Typically, cells reached
this stage of confluence in 7 to 10 days. Formost experiments
reported herein, RPG cells from passages 2 to 4 were em-
ployed. These cells were in culture from 3 to 8 weeks. Some
cells at passage 1 were stored in liquid nitrogen in a mixture
of 90% Hepato-STIM medium and 10% dimethyl sulfoxide.
Frozen cells could be recovered after 3 months (longest time
studied) of storage in liquid nitrogen. For experiments
to assess cell polarity, to measure transepithelial electrical
resistance (TER), or to assess fluid movement (see details
below), the passaged cells were grown on a polyester
filter (Transwell-Clear system; Corning Life Sciences, Ac-
ton, MA).
Cell line culture conditions
HSG cells (a generous gift of M. Sato, Tokushima Uni-
versity, Japan)18 were maintained in a 1:1 mixture of
DMEM/Ham’s F-12 (Biofluids) supplemented with 10%
fetal bovine serum (HyClone, Logan, UT), 100U/mL peni-
cillin, 100 mg/mL streptomycin, and 2.5 mg/mL Fungizone
(Biofluids) and cultured in a humidified atmosphere of 5%
CO2 at 378C. Madin-Darby canine kidney (MDCK)-II cells
were obtained from Clontech (Palo Alto, CA) and were
maintained in DMEM (Biofluids) with the same supple-
ments and growth conditions as used for HSG cells.
Antibodies
Mouse anti-zonula occludens (ZO)-1, rabbit anti-
claudin-1, and rabbit anti-claudin-3 antibodieswere obtained
from Zymed (San Francisco, CA). Mouse anti-E-cadherin,
mouse anti-vimentin (BD Pharminogen, San Diego, CA),
mouse anti-Naþ/ Kþ-adenosine triphosphatase (ATPase)
(Upstate Biotechnology, Lake Placid, NY), and rabbit anti-
aquaporin (AQP)1 (Alpha Diagnostic, San Antonio, TX)
were obtained as indicated. These antibodies are reactive
against their respective proteins frommonkeys, humans, and
several other species. Secondary antibodies, fluorescein
(FITC)-conjugated AffiniPure F (ab0)2 fragment, donkey
anti-rabbit immunoglobulin (Ig)G, and donkey anti-mouse
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IgG, were obtained from Jackson Immunoresearch Labora-
tories (West Grove, PA).
Confocal microscopy
Immunofluorescent staining was performed as described
previously.12 Cells, grown on Transwell-Clear filters, were
initially rinsed twice with phosphate-buffered saline (PBS
without calcium and magnesium; pH 7.4; Biofluids) before
being fixed with 3% paraformaldehyde in PBS for 30min.
Thereafter, the cells were rinsed twice with PBS and treated
with 100mM glycine in PBS for 20min. Cells were then
permeabilized with methanol at 208C for 5min and sub-
sequently incubated in a mixture of 5% donkey serum and
0.5% bovine serum albumin in PBS for 20min. Next, the
cells were incubated with the appropriate primary anti-
body for 1 h at room temperature. Thereafter, the FITC-
conjugated secondary antibody was incubated for 30min,
and cells were washed 3 additional times for 3min each with
PBS before the filter containing the cells was excised from its
support and mounted onto a slide with Vectashield con-
taining 40-6-diamidino-2-phenylindole or propidium iodide
(Vector Laboratories, Inc., Burlingame, CA). Expression of
ZO-1, claudin-1, claudin-3, Naþ/ Kþ-ATPase, E-cadherin,
and vimentin using confocal microscopy was observed using
a Leica TCS SP2 scanner (Bensheim, Germany) with Leica
confocal software.
Measurement of TER and fluid movement
Cells were seeded on 24-mm Transwell-Clear polyester
filters and grown as above. The upper chamber containing
the cells received 1.5mL of medium, and the lower cham-
ber received 2.6mL of medium. TER was measured when
the cells (RPG, MDCK, or HSG) were confluent, using a
Millicell ERS epithelial volt-ohmmeter (Millipore Corp.,
Allen, TX) as described by the manufacturer. TER readings
from filters without cells were subtracted from readings
obtained from filters seeded with cells.
Transepithelial fluid movement was measured as de-
scribed previously,12,19 using hyperosmotic medium in the
apical chamber (440mosm) and isosmotic medium in the
basal chamber (340mosm). After the cells formed a con-
fluent monolayer, 0.4mL of normal growth medium sup-
plemented with 100mosm sucrose was put in the upper
chamber, and 2.6mL normal growth medium was put in the
lower chamber. The cells were incubated for 30min in a
humidified atmosphere of 5% CO2 at 378C, after which the
medium in the upper chamber was removed and measured
gravimetrically.
Measurement of RPG cell growth on PLLA disks
PLLA (Boehringer Ingelheim Inc., Winchester, VA)
disks were produced by melt-processing polymer pellets
between sheets of aluminum foil using a Carver press at
3508F to create disks with diameters of 20 to 25mm. The
disks were sterilized in 80% ethanol for 30min. The ster-
ilized disks were next coated using incubation in solutions
of 20 mg/mL fibronectin (BD Biosciences, Bedford, MA)
or 20 mg/mL collagen I (Cohesion Technologies, Inc., Palo
Alto, CA) for 18 h at 378C. Thereafter, the disks were
placed in each well of a 6-well tissue culture plate (Becton
Dickinson, Franklin Lakes, NJ). Cell suspensions (2.5105
RPG cells/well) were added in culture medium and in-
cubated for up to 10 days. Cell number was measured as
previously described.9 Briefly, at 2, 4, 6, 8, and 10 days, the
disks were removed from the wells, stained with 0.2%
crystal violet in 20% ethanol for 10min, and then rinsed
twice with distilled water. Using an inverted light micro-
scope, the cell number was counted in 3 randomly chosen
200-mm2 regions from each disk.
Recombinant virus production
An adenovirus encoding human aquaporin-1 (AdhAQP1),
an adenovirus encoding the green fluorescent protein
(AdGFP), and an adeno-associated virus 2 encoding human
aquaporin-1 (AAV2hAQP1) were constructed and purified,
and titers were determined as described previously.4,19,20
Recombinant AAV2 and AAV5 vectors, containing a Rous
sarcoma virus promoter GFP expression cassette, were pro-
duced as previously described,21 and particle titers deter-
mined using quantitative polymerase chain reaction. Before
transduction, virus particles were dialyzed against DMEM for
3 h at room temperature. Dialyzed virus was then added to
cells and incubated for the indicated times in DMEM. The
following day, the virus-containing medium was removed
and replaced with 200mL of complete media and the cells
assayed for transduction.
Transduction with AdhAQP1 and
AAVhAQP1 promotes fluid movement
After RPG cells formed a confluent monolayer on
Transwell filters, they were incubated with AdhAQP1 or
AdGFP vectors at a multiplicity of infection (MOI; defined
as plaque-forming units/cell) of 1 on the apical surface.
Transductions with AAV2hAQP1 and adeno-associated
virus 2 encoding the green fluorescent protein (AAV2GFP)
were performed at a MOI (defined as particles/cell) of
1000, also delivered at the apical surface. Fluid movement
was measured, as described above, 24 h (AdhAQP1) or up
to 72 h (AAV2hAQP1) after exposure to vectors to evaluate
function of the transgenic hAQP1. Thereafter, the cells
were stained with AQP1 antibody to detect hAQP1 and
count the number of AQP1-positive cells. Cell number was
counted in 3 rectangular frames under a microscope (Leica
DM RE-7 SDK) at 100magnification.
Statistical analysis
Data are reported as mean values standard error of the
mean. Significant differences in TER or fluid movement
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FIG. 1. Morphological and growth characteristics of rhesus parotid gland (RPG) cells. (A) Phase contrast micrograph showing the
appearance of RPG cells during primary cell culture, typical for passages 1–4. Magnification 100. (B) Time course of RPG cell growth
on the poly-L-lactic acid (PLLA) disks coated with fibronectin or collagen I. RPG cells (2.5105 cells/mL; 2mL) were seeded on PLLA
disks after coating overnight with fibronectin (20mg/mL) or collagen I (20mg/mL) and incubated for 2, 4, 6, 8, and 10 days. The results
represent the average standard error of the mean of 3 separate determinations. Inset photographs show the appearance of RPG cells on
each of the above days and growth conditions after staining with 0.2% crystal violet in 20% ethanol. (C) Confocal photomicrograph
showing the presence of the epithelial protein marker E-cadherin in RPG cells. Nuclei are stained with propidium iodide. Bar¼ 20 mm.
(D) Confocal photomicrograph showing the distribution of the Naþ/ Kþ-ATPase in RPG cells. Nuclei are stained with DAPI. The x-z
image shows that Naþ/ Kþ-adenosine triphosphatase is localized to the basolateral membranes (arrow). Bar¼ 50 mm. (E) Confocal
photomicrograph showing the localization of the tight junction protein zonula occludens (ZO)-1 in RPG cells. Nuclei are stained with
40-6-diamidino-2-phenylindole. In the x-z image, ZO-1 is seen as distinct dots (arrows) appropriately localized toward the apical side.
Bar¼ 50mm. (F) Confocal photomicrograph showing the localization of claudin-1 in RPG cells. Nuclei are stained with propidium
iodide. In the x-z image, claudin-1 is seen localized in lateral membranes between neighboring cells (arrows). Bar¼ 50 mm. Color
images available online at www.liebertpub.com/ten.
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were assessed using a 1-way analysis of variance followed
by Fisher’s protected least significant difference test.
RESULTS AND DISCUSSION
Morphological characterization of
rhesus parotid epithelial cells
The mechanically and enzymatically digested rhesus
parotid tissue initially consisted of floating clumps of cells.
Within 6 h after plating, some cells (clumps) started to attach
to the bottom of the dish. Small circumferential islands
(10–20 cells) of epithelial-like cells were observed from day
1 after plating. As the cells proliferated and spread, these
islands enlarged until they contacted each other to form an
epithelial-like sheet of round, oval, and polygonal cells
(Fig. 1A). The RPG cells took approximately 7 to 10 days to
attain 80% confluence.When RPG cells were grown on disks
composed of PLLA, a useful biodegradable substratum,
coated with fibronectin or collagen I, the cell number in-
creased slowly over the first 4 days. Thereafter, cell growth
was rapid, increasing until day 8, before reaching a plateau
with RPGcells exhibiting an epithelioid appearance (Fig. 1B).
We next evaluated RPG cells for expression and locali-
zation of several key proteins using confocal microscopy. As
shown in Fig. 1C, RPG cells uniformly express E-cadherin,
which indicates their epithelial nature. When cells were
probed with an antibody to vimentin, which is a marker of
mesenchymal cells, they were uniformly negative (not
shown). To assess whether the cells were morphologically
polarized, we initially probed the cells with antibody to the
Naþ/Kþ-ATPase. In polarized epithelial cells, this mol-
ecule is found on the basolateral membranes. In RPG cells,
the Naþ/Kþ-ATPase was clearly localized to this membrane
domain (Fig. 1D; x-y and x-z images). ZO-1 is a key tight-
junction component, normally found toward the apical re-
gion between adjacent epithelial cells.22 As shown in Fig.
1E, probing of RPG cells with antibody to ZO-1 revealed the
presence of hexagonal labeling of the plasma membrane in
the x-y plane, with a discrete dot-shaped localization toward
the apical region when viewed in the x-z plane. Claudin-1 is
another key component of tight junctions typically detected
along the lateral membranes between neighboring cells.23 As
shown in Fig. 1F (x-y and x-z images), incubating RPG cells
with antibody to claudin-1 labeled the lateral membranes.
RPG cells, however, were not stained with an antibody to
claudin-3 (not shown), which suggested that they were of
duct cell origin (Tran et al., unpublished). These aggregate
results suggest that RPG cells attain a correct morphological
polarization when grown in vitro on Transwell filters.
Functional characterization of rhesus
parotid epithelial cells
We next examined 2 important functional aspects of a
polarized epithelium in the RPG cell monolayers: the ability
to generate a TER and to serve as a physiological barrier.
Initially, we compared the TER generated by RPG cells with
that ofMDCKcells, as a positive control, andHSG cells, a cell
line incapable of forming tight junctions,11 as a negative con-
trol. As shown in Fig. 2A, RPG cells were able to generate
FIG. 1. (Continued)
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amodestTER(*135 O  cm2),whereasMDCKcellsdisplayed
higher TER values (*300 O  cm2). HSG cells displayed very
low TERs (*20 O  cm2). The TER levels generated by RPG
cells ( p< 0.01) and MDCK cells ( p< 0.01) were sig-
nificantly different from those of HSG cells.
Paracellular fluid movement was employed as an indicator
of membrane barrier function, and we compared results with
RPG, MDCK, and HSG cells. As shown in Fig. 2B, HSG
cells, again used as a negative control, were unable to provide
an effective barrier to fluid movement in response to an
imposed osmotic gradient, 440mosm apical to 340mosm
basal (*6.5mL/cm2 over 30min). Conversely, MDCK cells
FIG. 2. Functional traits of rhesus parotid gland (RPG) cells.
(A) Transepithelial electrical resistance (TER) was measured as
described in Materials and Methods. Madin-Darby canine kidney
(MDCK) cells are used as a positive control. RPG cells showed
significantly higher TER than that of HSG cells, used as a negative
control. The results represent the average standard error of the
man (SEM) of 5 separate determinations for RPG cells, 8 separate
determinations for HSG cells, and 7 separate determinations for
MDCK cells. (B) Paracellular fluid movement was measured as
described in Materials and Methods. The restriction of fluid
movement by RPG cells was significantly greater than that by
HSG cells, which served as a negative control. MDCK cells are
used as a positive control. The results represent the average
SEM of 4 separate determinations for RPG cells and 6 separate
determinations each for HSG cells and MDCK cells. For these
experiments, cells were seeded on day 0. Subsequently, on days
1–3, cells were tested for TER, as well as observed micro-
scopically for visual confluence. On day 3, RPG and MDCK cells
achieved confluence according to visual examination and dis-
played high TER levels. Although HSG cells appeared to attain
confluence visually at this time, they did not show elevated TER.
Thus, before measuring fluid movement in these experiments,
RPG and MDCK cells exhibited high TER.
FIG. 3. Effect of adeno-associated virus type 2 (AAV2) and
AAV5 vectors on transduction of rhesus parotid gland (RPG)
cells. Primary cultures of RPG cells were transduced with AAV2
or AAV5 vectors encoding green fluorescent protein (GFP). RPG
cells were incubated with 5104 adeno-associated virus encoding
the green fluorescent protein particles/cell. Pictures of GFP-
transduced cells were taken using a Nikon DXM12000F digital
camera mounted on a fluorescent microscope with a Nikon 10X,
0.25 N.A. objective. Images were acquired using Nikon ACT-1
software. Transduction was followed over time, and the percen-
tage of transduced cells was quantified using manual counting.
Specifically, the percentage transduction was determined as fol-
lows. The field was divided into quadrants, and the number of
positive cells and the total number of cells in each quadrant were
counted. Cells were counted in 2 independent fields in each ex-
periment. (A) RPG cells 15 days post-transduction with the AAV2
vector. (B) RPG cells 15 days post-transduction with the
AAV5 vector. (C) RPG cells 45 days post-transduction with the
AAV5 vector. Data shown are representative of 2 independent
experiments. Color images available online at www.liebertpub
.com/ten.
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were able to effectively limit the movement of fluid from the
basal to the apical culture chamber in response to this same
osmotic gradient (*2.0mL/cm2; p< 0.01 vs HSG cells).
RPG cells were able to limit the fluid movement almost as
effectively as MDCK cells (2.6mL/cm2; p< 0.01).
Susceptibility of RPG cells to transduction
with AAV serotypes 2 and 5
Previously, we demonstrated that duct cells in murine
salivary glands are permissive for several different ser-
otypes of AAV but differ in their transduction activity.24–26
For example, although approximately 27% of the cells per
duct were transduced with AAV2 vectors at 6 weeks post-
infusion, approximately 46% were transduced with AAV5
vectors at the same dose when assayed using immuno-
histochemical staining for GFP expression.26 Similar dif-
ferences in transduction activity were also observed with
vectors encoding b-galactosidase and when using quanti-
tative polymerase chain reaction to measure the number of
vector genomes in isolated glands.26
We therefore compared the relative transduction activity
of AAV2 and AAV5 vectors containing GFP expression
cassettes in cultures of RPG cells over time. In agreement
with previous reports of transduction experiments with
primary cells, the kinetics of AAV vector transduction were
considerably slower than that observed with established
cell lines.27 At a MOI of 5104 particles/cell, transduction
was initially detected at 15 days post-incubation and dif-
fered substantially between the two serotypes (Fig. 3;
AAV2>AAV5). Although approximately 20% of the RPG
cells incubated with AAV2 were positive for GFP expres-
sion at this time, fewer than 1% of the cells incubated with
AAV5 were positive (Fig. 3A, B). However, by day 45
after exposure to vector, the relative transduction activity of
the 2 vectors was different. AAV2 transduction remained at
approximately 20% (not shown), but AAV5 transduction of
RPG cells had increased to approximately 80% (Fig. 3C). At
both time points, with both vectors, there was considerable
variation from cell to cell in the level of GFP expression
detected. Some RPG cells were highly transduced, whereas
others exhibited only low levels of transduction. These
general results mirror our earlier in vivo experiments with
mice26 and suggest that multiple serotypes of AAV will be
useful for transducing primate salivary glands in vivo.
Functional re-engineering of RPG cells
Using the RPG cell model glandular epithelia, we tested
the potential for functional re-engineering of these cells using
adenoviral and AAV vectors encoding the archetypical water
channel hAQP1.17 Transfer of the hAQP1 cDNA with the
AdhAQP1 vector is useful for correcting irradiation-induced
salivary hypofunction in rats and minipigs.4,6 For these ex-
periments, control RPG cells were transduced with vectors
encodingGFP. Therewere no hAQP1-immuno-positive RPG
cells observed 24 h after exposure toAdGFP (not shown), and
the rate of fluid movement in response to an imposed osmotic
gradient (440mosm to 340mosm; apical to basal) was
1.4mL/cm2 per 30min (Table 1). Conversely, 24 h after
transduction with AdhAQP1 approximately 15% of the cells
were hAQP1 immuno-positive (Fig. 4A), and their rate of
fluidmovement was elevatedmore than 3-fold, to 5.0mL/cm2
per 30min. Seventy-two h after transduction with AAV2-
hAQP1,19 approximately 9% of RPG cells were hAQP1
immuno-positive (Fig. 4B–D), and these cells also exhibited
a marked increase (*6-fold) in the rate of fluid movement
(Table 1; 5.9mL/cm2 per 30min) versus that seen after
transduction of cells with AAV2GFP (0.9 mL/cm2; no hAQP1
immuno-positive cells detected; not shown). Based on pre-
vious in vitro studies with a model polarized rat salivary
epithelium in vitro, it is likely that even low levels of hAQP1
would be sufficient for achieving substantial transepithe-
lial fluid movement in vivo.28 However, it may be that the
levels of fluid movement achieved with RPG cells herein
would be insufficient to provide adequate moisture for pa-
tients’ mouths. In that case, it should be possible to increase
the dose of vector used to transduce the cells, which con-
sequently should lead to significant increases in fluid
movement.28
TABLE 1. EFFECT OF AQUAPORIN-1 ENCODING VIRAL VECTORS ON FLUID MOVEMENT ACROSS MONOLAYERS OF RHESUS
PAROTID GLAND (RPG) CELLS
Vector
Adenovirus encoding human
aquaporin-1 positive cells (%)
Fluid movement (mL/cm2
standard error of the mean)
AdGFP1 none 1.4 0.7
AdhAQP11 14.6 1.1 5.0 0.4
AAV2GFP2 none 0.9 0.2
AAV2hAQP12 9.2 1.7 5.9 0.7
1Measured at 24 h post-transduction with multiplicity of infection (MOI)¼ 1 plaque-forming unit/cell.
2Measured at 72 h post-transduction with MOI¼ 1000 particles/cell.
The time points selected for performing fluid movement measurements were chosen for experimental convenience and because of clearly demonstrable
human aquaporin-1 expression (see Fig. 4). For the experiments reported in this table, transepithelial electrical resistance (TER) was measured before and
after transduction of RPG cells with the indicated vectors. These vectors had no effect on TER measurements; before performing fluid-movement assays,
all RPG cells exhibited high TER. See Materials and Methods for additional details.
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CONCLUSIONS
In the present study, we have achieved 3 major findings.
First, we show that primary cultures of RPG cells are
capable of attaining a polarized orientation, as demon-
strated by the correct localization of Naþ/Kþ-ATPase, ZO-
1, and claudin-1.22,23 Second, we show that RPG cells
exhibit an essential epithelial function required for graft
cells in an artificial salivary gland device: the presence of
an effective membrane barrier limiting paracellular water
permeability and resulting in a significant TER. Third, we
show that RPG cells can express functional water channels,
capable of mediating directional fluid movement, after
transduction by adenoviral and AAV2 vectors encoding
hAQP1. These results indicate that it is feasible to achieve
the functional re-engineering of such duct-like cells for
their eventual use in an artificial salivary gland. It remains
to be shown whether RPG cells are capable by themselves
of generating an osmotic gradient and driving fluid secre-
tion through the transferred AQP1 channels or whether
further re-engineering would be required (e.g., insertion of
Cl entry or exit pathways).14,15 Such re-engineering, at
least for testing a prototype, could be achieved with AAV2
or AAV 5 vectors. Both vector serotypes convey con-
siderable stability of transgene expression when used to
transduce murine salivary duct cells.24,26
In aggregate, we suggest that these findings provide a
strong impetus for the development of a prototype device
FIG. 4. Expression of human aquaporin-1 (hAQP1) in rhesus parotid gland (RPG) cells transduced with an adenovirus encoding
human aquaporin-1 (AdhAQP1) or an adeno-associated virus encoding 2 human aquaporin-1 (AAV2hAQP1). RPG cells were exposed
to AdhAQP1 for 24 h (multiplicity of infection (MOI)¼ 1) or AAV2hAQP1 for 72 h (MOI¼ 1000), as described in Materials and
Methods and in Table 1. Cells were stained with an antibody to hAQP1, and nuclei were labeled with propidium iodide. Bar¼ 200 mm.
Color images available online at www.liebertpub.com/ten.
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capable of being tested in vivo in rhesus monkeys. As we
previously showed, for in situ testing of a functional artificial
salivary gland, a large animal is required, as is an autologous
graft cell.11,16 As shown herein, rhesus parotid glands pro-
vide an excellent model for such studies. Each individual
animal could provide a cell source via a biopsy of the tail
region of the parotid gland with minimal morbidity. While
the biopsy site healed, cells could be prepared and re-en-
gineered as required and the device fabricated. Thereafter, it
could be implanted via a small incision (pouch) in the buccal
mucosa, sutured to provide an orifice, and tested for secre-
tion after healing of the surgical wound. If effective, such a
device could provide benefit to many patients who currently
lack satisfactory treatment options.29,30
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